US approves Ranbaxy's generic Biaxin antibiotic

By siliconindia staff writer   |   Monday, 27 September 2004, 07:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc's antibiotic Biaxin, the FDA said on Saturday.
Biaxin had sales worth $538 million in the US in 2003.

Earlier this year, the FDA had approved generic Biaxin forms from Andrx Corp and Roxane Laboratories.



SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..